Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionHsbc Holdings Plc
Latest Disclosed Ownership21,517 shares
Latest Disclosed Value $ 310,598
Hsbc Holdings Plc ownership in FOLD / Amicus Therapeutics, Inc.

On April 30, 2026 - Hsbc Holdings Plc filed a 13F-HR form disclosing ownership of 21,517 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $311,136 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 13, 2025 disclosing 0 shares of Amicus Therapeutics, Inc.. The current value of the position is $311,781 USD.

Hsbc Holdings Plc has a history of taking positions in derivatives of the underlying security (FOLD) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

FOLD / Amicus Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 21,517 21,517 311 0.0000
2025-11-13 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -65,044 -100.00 0 -100.00
2025-08-13 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 65,044 14,588 28.91 377 -8.52 0.0002
2025-05-14 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 50,456 8,536 20.36 412 4.31 0.0003
2025-02-14 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 41,920 18,964 82.61 395 60.16 0.0002
2024-11-14 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 22,956 -8,317 -26.59 247 -20.13 0.0001
2024-08-12 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 31,273 809 2.66 308 -13.97 0.0002
2024-05-15 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 30,464 30,464 359 0.0002
2021-11-12 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -10,340 -100.00 0 -100.00
2021-08-13 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 10,340 10,340 102 0.0001
2021-05-14 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -33,262 -100.00 0 -100.00
2021-02-25 2020-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 33,262 33,262 772 0.0010
2021-02-12 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 32,101 32,101 745 176.8904
2020-11-12 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -12,667 -100.00 0 -100.00
2020-08-14 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 12,667 12,667 191 0.0004
2020-05-15 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -25,220 -100.00 0 -100.00
2020-02-14 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 25,220 -21,285 -45.77 247 -33.78 0.0004
2019-11-14 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 46,505 46,505 84.40 373 51.01 0.0007
2018-08-10 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -133,594 -100.00 0 -100.00
2018-05-11 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 133,594 133,594 2,009 0.0030
2017-05-15 2017-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -24,543 -100.00 0 -100.00
2017-02-09 2016-12-31 13F AMICUS THERAPEUTICS COM 03152W109 24,543 24,543 122 0.0003
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-14 2021-03-31 13F AMICUS THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-12 2020-12-31 13F AMICUS THERAPEUTICS COM Put 1,161 27 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.